A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease

Documenti analoghi

• Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
  di: Raimo K. Tuominen, et al.
  Pubblicazione: (2024)
• Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
  di: Camila de Oliveira Vian, et al.
  Pubblicazione: (2024)
• Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review
  di: Shokouh Arjmand, et al.
  Pubblicazione: (2024)
• The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms
  di: Mohsen Karbasi Yazdi, et al.
  Pubblicazione: (2024)
• Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
  di: Maria de Fátima dos Santos Sampaio, et al.
  Pubblicazione: (2024)